Search CROs

• Analytical Method Development & Validation
• Bioanalysis
• Bioinformatics & Data Science

Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.

• Cardiovascular & Metabolic Specialty Services
• In Vitro Pharmacology
• In Vivo Efficacy Models

Cardiomedex is a preclinical CRO specialized in cardiovascular disease models, offering in vivo efficacy studies, ex vivo functional exploration, and in vitro assays for drug candidates targeting heart failure, myocardial infarction, hypertension, and cardiometabolic complications.

Preclinical CRO providing integrated research services including efficacy testing, disease model development, PK/PD, toxicology, biomarker research, and safety assessment across respiratory, ophthalmology, cardiovascular, and neurology therapeutic areas.

• GLP Toxicology
• High-Throughput Screening
• In Vitro ADME / DMPK

Creative Bioarray provides preclinical research solutions including drug screening, ADME-PK, toxicity studies, and cell-based services across oncology, neurology, cardiovascular, and metabolic therapeutic areas.

• Bioanalysis
• Bioinformatics & Data Science
• Biomarker Assays

Danish CRO offering in vivo models, proteomics, transcriptomics, biomarker discovery, and bioinformatics to support biotech and pharma research from concept to validated data.

• Bioanalysis
• Carcinogenicity Studies
• Cardiovascular & Metabolic Specialty Services

Inotiv provides integrated preclinical and safety assessment services including toxicology, bioanalysis, pathology, and specialized research models across discovery through IND-enabling phases.

• Analytical Method Development & Validation
• Bioanalysis
• Biomarker Assays

Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.

• Immunology & Inflammation Services
• In Vitro Pharmacology
• In Vivo Efficacy Models

Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical drug discovery, with specialized platforms including HUGO-GT™ and HUGO-Ab™ for humanized target validation and antibody screening.

• In Vitro Pharmacology
• In Vivo Efficacy Models
• In Vivo PK / PD Studies

GemPharmatech develops and supplies genetically engineered mouse models (GEMMs) and preclinical research services using CRISPR/Cas9 and gene-editing technologies, with a library of 25,000+ mouse strains including KO/cKO, humanized, and immunodeficient models.

• Computational & In-Silico Drug Discovery
• Discovery Research
• GLP Toxicology

ChemDiv is a fully integrated target-to-clinic CRO headquartered in San Diego, CA, offering drug discovery services including medicinal chemistry, CADD, ADME/DMPK, toxicology, and custom synthesis alongside the industry's largest commercial screening library of 1.6M compounds.

• Bioanalysis
• Bioinformatics & Data Science
• Biomarker Assays

Axcelead provides integrated drug discovery research services to pharmaceutical companies, biotech ventures, and academic institutions. Founded in 2017 from Takeda's drug discovery research base, the company offers expertise across small molecules, nucleic acids, antibodies, and multiple therapeutic modalities.

• Bioanalysis
• Cardiovascular & Metabolic Specialty Services
• CNS Specialty Services

Michigan-based preclinical CRO specializing in targeted drug delivery, molecular biology, and bioanalysis with three GLP-compliant facilities supporting non-GLP and GLP safety assessment studies.

• Bioanalysis
• Biomarker Assays
• Biostatistics & Statistical Programming

Sapient provides multi-omics biomarker discovery services—proteomics, metabolomics, and cytokine profiling—paired with biocomputational analysis and real-world validation to support drug development decisions across all phases.

• Analytical Method Development & Validation
• Bioanalysis
• Bioinformatics & Data Science

HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally.